Tagata, Letecia M.

HRN: 21-37-73  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/13/2025
CEFTRIAXONE 1G (VIAL)
06/13/2025
06/19/2025
IV
2g
OD
CAP MR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: